Abstract
Human medicines European public assessment report (EPAR): Praxbind, idarucizumab, Hemorrhage, Date of authorisation: 20/11/2015, Revision: 6, Status: Authorised
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
